Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus.

Verdecchia, Paolo; Angeli, Fabio; Reboldi, Gianpaolo

Verdecchia, Paolo; Angeli, Fabio; Reboldi, Gianpaolo.

Verdecchia P; Fondazione Umbra Cuore e Ipertensione-ONLUS and Struttura Complessa di Cardiologia, Ospedale S. Maria della Misericordia, Perugia.
Angeli F; Department of Medicine and Surgery, University of Insubria, Varese and Department of Medicine and Cardiopulmonary Rehabilitation, Maugeri Care and Research Institute.
Reboldi G; Department of Medicine, University of Perugia, Italy.

J Hypertens ; 38(6): 1190-1191, 2020 06.

Article in English | MEDLINE | ID: covidwho-175439

Subject(s)

Angiotensin Receptor Antagonists; Coronavirus; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Betacoronavirus; COVID-19; Coronavirus Infections; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Coronavirus / Angiotensin Receptor Antagonists Limits: Humans Language: English Journal: J Hypertens Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google